NDA
Bejelentkezés
Kapcsolat
Cross metathesis with hydroxamate and benzamide BOC-protected alkenes to access HDAC inhibitors and their biological evaluation highlighted intrinsic activity of BOC-protected dihydroxamates |
Tartalom: | http://real.mtak.hu/34688/ |
---|---|
Archívum: | MTA Könyvtár |
Gyűjtemény: |
Status = Published
Type = Article |
Cím: |
Cross metathesis with hydroxamate and benzamide BOC-protected alkenes to access HDAC inhibitors and their biological evaluation highlighted intrinsic activity of BOC-protected dihydroxamates
|
Létrehozó: |
Zwick, V.
Nurisso, A.
Simões-Pires, C.
Bouchet, S.
Martinet, N.
Lehotzky, Attila
Ovádi, Judit
|
Kiadó: |
Elsevier
|
Dátum: |
2016
|
Téma: |
RC0254 Neoplasms. Tumors. Oncology (including Cancer) / daganatok, tumorok, onkolĂłgia
|
Nyelv: |
angol
|
Típus: |
Article
PeerReviewed
info:eu-repo/semantics/article
|
Formátum: |
text
|
Azonosító: |
Zwick, V. and Nurisso, A. and Simões-Pires, C. and Bouchet, S. and Martinet, N. and Lehotzky, Attila and Ovádi, Judit (2016) Cross metathesis with hydroxamate and benzamide BOC-protected alkenes to access HDAC inhibitors and their biological evaluation highlighted intrinsic activity of BOC-protected dihydroxamates. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 26 (1). pp. 154-159. ISSN 0960-894X
|
Kapcsolat: |
https://dx.doi.org/10.1016/j.bmcl.2015.11.011
MTMT:2977992; doi:10.1016/j.bmcl.2015.11.011
|